Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping
Journal article published in 2018 by
George Papaxoinis 
,
Vassiliki Kotoula,
Eleni Giannoulatou,
Georgia-Angeliki Koliou,
Vasilios Karavasilis,
Sotirios Lakis,
Andreas Koureas,
Mattheos Bobos,
Elpida Chalaralambous,
Emily Daskalaki,
Kyriakos Chatzopoulos,
George Tsironis,
Elisavet Pazarli,
Sofia Chrisafi,
Epaminontas Samantas
and other authors.
,
Vassiliki Kotoula,
Eleni Giannoulatou,
Georgia-Angeliki Koliou,
Vasilios Karavasilis,
Sotirios Lakis,
Andreas Koureas,
Mattheos Bobos,
Elpida Chalaralambous,
Emily Daskalaki,
Kyriakos Chatzopoulos,
George Tsironis,
Elisavet Pazarli,
Sofia Chrisafi,
Epaminontas Samantas
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 